Cancer immunotherapy implants get boost by Novartis licensing – STAT
STAT |
Cancer immunotherapy implants get boost by Novartis licensing
STAT ancer immunotherapy 1 — the process of activating a patient's own immune system to fight a tumor — is a booming field in drug development. But it faces certain hurdles. Fewer than a quarter of cancer patients benefit from leading drugs in the class … |
